Business, General, News Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial August 20, 2024 The late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period.
US considers lifting sanctions on some Iranian oil Treasury Secretary Scott Bessent broached waiving sanctions on oil already at sea, which would be a stunning reversal of longstanding…
How to Design a Persistent Memory and Personalized Agentic AI System with Decay and Self-Evaluation? In this tutorial, we explore how to build an intelligent agent that remembers, learns, and adapts to us over time.…
Ukraine struggling to keep lights on under Russian attack, says energy boss DTEK boss Maxim Timchenko says the intensity of Russian strikes is so frequent there is no time to recover.